Winston Taylor boasts deep proficiency across all areas of patent law, catering to clients in sectors including life sciences, technology, telecoms, consumer and retail. The department is co-led by Wim Maas, who handles high-stakes patent litigation and IP seizures across the electronics, mechanical engineering, biotechnology, and pharmaceuticals segments. Also co-heading the team is Bas Berghuis van Woortman, who joined in August 2025 and specialises in patent and technology-focused IP litigation, while also advising on licensing, prosecution strategy, R&D agreements, and trade secret protection. Also in August 2025, the team hired Sebastien Versaevel and Diptanil Debbarma, followed by Daisy Termeulen in December 2025. Eelco Bergsma and Charlotte Garnitsch departed the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Taylor Wessing’s patent litigation practice distinguishes itself in the market through a combination of deep sector knowledge, international reach, and the ability to deliver pragmatic, forward-looking solutions.’
‘Among standout individuals, Pauline Springorum has established herself as a “new star” in patent litigation, with particular expertise in guiding clients through the complexities of UPC procedures.'
'Wim Maas is widely recognised for his strategic insights: he excels at framing litigation not only in terms of the immediate proceedings but in the broader commercial and competitive context.’
‘We are very happy with the services provided by Taylor Wessing on our patent litigation matters. They are consistently responsive and creative in finding practical solutions, and they clearly understand our commercial interests.’
‘Wim Maas and David Mulder have been highly reliable and proactive—very responsive, creative in proposing solutions, and deeply knowledgeable about the technical aspects of our patents.’
Key clients
- Pfizer
- Abbott
- Ericsson
- Accord Healthcare
- XPENG
- Walt Disney Company
- Tandem Diabetes Care
- Easee
- Wensch Product Development
- Tenways
- CEAD B.V.
- Fresenius
Work highlights
Acting in Pfizer v. BioNTech and Moderna - high-profile patent litigation concerning the COVID-19 vaccine.
Acting in Abbott v. Sibionics - patent litigation regarding continuous glucose monitoring (CGM) devices.
Acting in Ericsson v. ASUS - patent litigation concerning several telecom patents (SEPs) relating to the 5G standard for communication.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Wim Maas; Bas Berghuis van Woortman
Other key lawyers
Sebastien Versaevel; David Mulder; Geert Theuws; Pauline Springorum; Faziel Abdul; Daisy Termeulen; Diptanil Debbarma; Sophie van Asten